Comparison of Pre-Endoscopic C-WATCH Score with Established Risk Assessment Tools in Patients with Upper Gastrointestinal Bleeding.


Journal

Digestive diseases (Basel, Switzerland)
ISSN: 1421-9875
Titre abrégé: Dig Dis
Pays: Switzerland
ID NLM: 8701186

Informations de publication

Date de publication:
2022
Historique:
received: 15 10 2021
accepted: 18 01 2022
pubmed: 25 1 2022
medline: 19 11 2022
entrez: 24 1 2022
Statut: ppublish

Résumé

Use of risk scores for early assessment of patients with upper gastrointestinal bleeding (UGIB) is recommended by various guidelines. We compared Cologne-WATCH (C-WATCH) score with Glasgow-Blatchford score (GBS), Rockall score (RS), and pre-endoscopic RS (p-RS). Patients with UGIB between January and December 2017 were retrospectively analyzed for 30-day mortality and composite endpoints risk of complications and need for intervention using areas under the receiver-operating characteristics curve (AUROC). Subgroup analysis was conducted for patients with UGIB on admission and in-hospital UGIB. A total of 252 patients were identified (67.5% men, mean age 63.8 ± 14.9 years). In-hospital UGIB occurred in 49.6%. AUROCs for 30-day mortality, risk of complications, and need for intervention (not applicable to RS) were 0.684 (95% confidence interval [CI]: 0.606-0.763), 0.665 (95% CI: 0.594-0.735), and 0.694 (95% CI: 0.612-0.775) for C-WATCH score, 0.724 (95% CI: 0.653-0.796) and 0.751 (95% CI: 0.687-0.815) for RS, 0.652 (95% CI: 0.57-0.735), 0.653 (95% CI: 0.579-0.727), and 0.673 (95% CI: 0.602-0.745) for p-RS and 0.652 (95% CI: 0.572-0.732), 0.663 (95% CI: 0.592-0.734), and 0.752 (95% CI: 0.683-0.821) for GBS. RS outperformed pre-endoscopic scores in predicting risk of complications, while there were no significant differences between pre-endoscopic scores except GBS outperforming p-RS in predicting need for intervention. The subgroup analysis obtained similar results. Positive predictive values for patients with estimated low risk for all three endpoints (C-WATCH score ≤1, RS ≤2, p-RS <1, and GBS ≤1) were 89%, 69%, 78%, and 92%. C-WATCH score performed similar to the established pre-endoscopic risk scores in patients with UGIB regarding relevant patient-related endpoints with no significant differences between both the subgroups.

Identifiants

pubmed: 35073555
pii: 000522121
doi: 10.1159/000522121
pmc: PMC9808639
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

826-834

Informations de copyright

© 2022 The Author(s). Published by S. Karger AG, Basel.

Références

Z Gastroenterol. 2017 Sep;55(9):883-936
pubmed: 29186643
Int J Colorectal Dis. 2005 Jul;20(4):368-75
pubmed: 15551100
World J Gastrointest Endosc. 2019 Dec 16;11(12):561-572
pubmed: 31839875
Am J Gastroenterol. 1995 Apr;90(4):568-73
pubmed: 7717312
J Clin Gastroenterol. 2005 Apr;39(4):321-7
pubmed: 15758627
Lancet. 2000 Oct 14;356(9238):1318-21
pubmed: 11073021
N Engl J Med. 2020 Apr 2;382(14):1299-1308
pubmed: 32242355
BMJ. 2017 Jan 4;356:i6432
pubmed: 28053181
Best Pract Res Clin Gastroenterol. 2008;22(2):209-24
pubmed: 18346679
Clin Gastroenterol Hepatol. 2015 Jan;13(1):115-21.e2
pubmed: 25058843
BMC Gastroenterol. 2018 Jun 28;18(1):98
pubmed: 29954332
Lancet. 1996 Apr 27;347(9009):1138-40
pubmed: 8609747
Gut. 2011 Oct;60(10):1327-35
pubmed: 21490373
Medicine (Baltimore). 2015 Sep;94(38):e1614
pubmed: 26402828
Gut. 1996 Mar;38(3):316-21
pubmed: 8675081
Aliment Pharmacol Ther. 2011 Aug;34(4):470-5
pubmed: 21707681
Endoscopy. 2012 Aug;44(8):731-9
pubmed: 22833020
BMJ. 1997 Aug 30;315(7107):510-4
pubmed: 9329304
Endoscopy. 2021 Mar;53(3):300-332
pubmed: 33567467
Gastroenterology. 2011 Jul;141(1):62-70
pubmed: 21447331
Lancet. 2009 Jan 3;373(9657):42-7
pubmed: 19091393
Radiology. 1982 Apr;143(1):29-36
pubmed: 7063747
World J Gastroenterol. 2012 Jun 14;18(22):2739-44
pubmed: 22719181
Gastrointest Endosc. 2015 Apr;81(4):882-8.e1
pubmed: 25484324
Gastrointest Endosc. 2002 Jan;55(1):1-5
pubmed: 11756905
J Clin Gastroenterol. 2014 Nov-Dec;48(10):e93-8
pubmed: 24518802
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
Medicine (Baltimore). 2019 May;98(21):e15716
pubmed: 31124950

Auteurs

Gabriel Allo (G)

Department of Gastroenterology and Hepatology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Martin Bürger (M)

Department of Gastroenterology and Hepatology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Johannes Gillessen (J)

Department of Gastroenterology and Hepatology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Philipp Kasper (P)

Department of Gastroenterology and Hepatology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Jeremy Franklin (J)

Institute of Medical Statistics and Computational Biology, University of Cologne, Cologne, Germany.

Vera Mück (V)

Department of Gastroenterology and Hepatology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Dirk Nierhoff (D)

Department of Gastroenterology and Hepatology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Hans-Michael Steffen (HM)

Department of Gastroenterology and Hepatology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Tobias Goeser (T)

Department of Gastroenterology and Hepatology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Christoph Schramm (C)

Clinic for Gastroenterology, Hepatology and Transplant Medicine, Essen University Hospital, Essen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH